Monoclonal anti-ganglioside antibody and its preparation
US5730981A · kind A · utility
2Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 1994 |
| Grant date | Mar 24, 1998 |
| Priority date | — |
| Expiry date | Oct 20, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to monoclonal antibodies of high avidity, which react specifically with the gangliosides GD3 and GQ1b, and to their use for detecting melanomas and other tumors or tissues expressing GD3 and GQ1b.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.